www.cytoreason.com Open in urlscan Pro
192.116.109.25  Public Scan

Form analysis
0 forms found in the DOM

Text Content

This website stores cookies on your computer. These cookies are used to improve
your website experience and provide more personalized services to you, both on
this website and through other media. To find out more about the cookies we use,
see our Privacy Policy.

We won't track your information when you visit our site. But in order to comply
with your preferences, we'll have to use just one tiny cookie so that you're not
asked to make this choice again.

Accept Decline
Skip to content
Open toolbar

Accessibility Tools

 * Increase Text
 * Decrease Text
 * Grayscale
 * High Contrast
 * Negative Contrast
 * Light Background
 * Links Underline
 * Readable Font
 * Reset

Skip to content

LATEST NEWS:


CYTOREASON AND PFIZER SIGN $110M COLLABORATION DEAL!

read all about it
 * Technology
 * Solutions
 * Resources
   * Press Releases
   * Media Coverage
   * Scientific Publications
   * Case studies
   * Blog
 * Company
 * Careers

Menu
 * Technology
 * Solutions
 * Resources
   * Press Releases
   * Media Coverage
   * Scientific Publications
   * Case studies
   * Blog
 * Company
 * Careers

Contact us
 * Home
 * Technology
 * Solutions
 * Resources
   * Press Release
   * Media Coverage
   * Scientific Publications
   * Case studies
   * Blog
 * Company
 * Careers
 * Contact us

Menu
 * Home
 * Technology
 * Solutions
 * Resources
   * Press Release
   * Media Coverage
   * Scientific Publications
   * Case studies
   * Blog
 * Company
 * Careers
 * Contact us

 * Home
 * Technology
 * Solutions
 * Resources
   * Press Release
   * Media Coverage
   * Scientific Publications
   * Case studies
   * Blog
 * Company
 * Careers
 * Contact us

Menu
 * Home
 * Technology
 * Solutions
 * Resources
   * Press Release
   * Media Coverage
   * Scientific Publications
   * Case studies
   * Blog
 * Company
 * Careers
 * Contact us


BRING DATA
TO LIFE

From trial and error to predictable medicine
See how disease models work



BRING DATA
TO LIFE

From trial and error to predictable medicine
See how disease models work


LATEST NEWS:


CYTOREASON AND PFIZER SIGN $110M COLLABORATION DEAL!

read all about it


THE CYTOREASON DISEASE MODEL

Think of it as the most comprehensive model of human diseases.
Modeling and comparing treatments and patient groups so you get a clear map of
disease and drug mechanisms.

get inside


MANAGE YOUR DRUG PORTFOLIO

Prioritize all of your programs, compare your treatments to competing
treatments, and your drugs across patient populations.


MANAGE YOUR DRUG PORTFOLIO

Prioritize all of your programs, compare your treatments to competing
treatments, and your drugs across patient populations.


SEE THE FOREST AND THE TREES

Give your scientist a deep profile of your drug, and your executive a bird’s-eye
view of your entire portfolio. One platform for all users.



SEE THE FOREST AND THE TREES


Give your scientist a deep profile of your drug, and your executive a bird’s-eye
view of your entire portfolio. One platform for all users.


LISTEN TO LIVING DATA

Base your decisions on the latest human data as your disease models are updated.
Use live results to make accurate predictions.


LISTEN TO LIVING DATA

Base your decisions on the latest human data as your disease models are updated.
Use live results to make accurate predictions.


KNOW THE RISK AHEAD

Connect molecular mechanisms to your drug’s performance and compare to other
drugs in the market. Follow early signals and gain long-term confidence.



KNOW THE RISK AHEAD


Connect molecular mechanisms to your drug’s performance and compare to other
drugs in the market. Follow early signals and gain long-term confidence.
Get inside the model


IN THE NEWS

Media Coverage
September 22nd, 2022


CYTOREASON, PFIZER INK $110M, 5-YEAR EXTENSION OF AI-POWERED DRUG DEVELOPMENT
DEAL

https://www.fiercebiotech.com/medtech/cytoreason-pfizer-ink-110m-five-year-extension-ai-powered-drug-development-deal
read more
Media Coverage
March 24th, 2022


POOLBEG PHARMA SIGNS FIRST OF ITS KIND AI DEAL WITH CYTOREASON


read more
Press Release
February 10th, 2022


CYTOREASON AND PFIZER EXTEND COLLABORATION TO LEVERAGE MACHINE LEARNING IN DRUG
DEVELOPMENT


read more
more news

''


THE DIFFERENCE BETWEEN USING CYTOREASON TECHNOLOGY AND NOT USING IT, IS THE
DIFFERENCE BETWEEN ENGINEERING AND ART.

''

MIKE VINCENT

SVP Immunology & Inflammation




HOME

 * Technology
 * Solutions
 * Company
 * Careers
 * Contact us

Menu
 * Technology
 * Solutions
 * Company
 * Careers
 * Contact us


RESOURCES

 * Press Releases
 * Media Coverage
 * Scientific Publications
 * Case studies
 * Blog

Menu
 * Press Releases
 * Media Coverage
 * Scientific Publications
 * Case studies
 * Blog

 * media@cytoreason.com

Accessibility | Terms of Use | Privacy Policy | All rights reserved CytoReason
LTD © 2022 | Designed and Developed by: Webnoise

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in
settings.

Accept
Close GDPR Cookie Settings
 * Privacy Overview
 * Strictly Necessary Cookies

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user
experience possible. Cookie information is stored in your browser and performs
functions such as recognising you when you return to our website and helping our
team to understand which sections of the website you find most interesting and
useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save
your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This
means that every time you visit this website you will need to enable or disable
cookies again.

Enable All Save Settings